Foster Group
VRTX icon

Foster Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Foster Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$303K Buy
580
+5
+0.9% +$2.56K 0.01% 246
2026
Q2 		$286K Buy
575
+81
+16% +$35.9K 0.01% 251
2026
Q1 		$221K Buy
+494
New +$230K 0.01% 256
2025
Q3 		– Sell
-462
Closed -$206K – 283
2025
Q2 		$206K Sell
462
-63
-12% -$29K 0.01% 250
2025
Q1 		$255K Buy
+525
New +$245K 0.01% 178

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Foster Group's VRTX Position: Q3 2026 in Review

Foster Group increased its Vertex Pharmaceuticals (VRTX) stake by 0.87% in Q3 2026, buying an estimated $2.56K and bringing the position to 580 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #246.

Foster Group first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. 291 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Foster Group held 580 shares of Vertex Pharmaceuticals worth $303K as of Q3 2026.
  • Foster Group bought 5 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.56K.
  • Vertex Pharmaceuticals made up 0.01% of Foster Group's portfolio in Q3 2026, its #246 holding.
  • Foster Group first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 291 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.